Cutaneous Plasmacytoma in Dogs: Diagnosis, Treatment, and Prognosis

By Emiel Maddens · Reviewed in consultation with licensed veterinary professionals · Updated August 2026 · 9 min read

What Is Cutaneous Plasmacytoma in Dogs?

Cutaneous plasmacytoma is a benign skin tumor formed by an abnormal clonal population of plasma cells, the antibody-producing white blood cells that normally live in bone marrow and lymphoid tissue. When these cells form a mass in the skin or at a mucocutaneous junction (where haired skin meets moist tissue such as the lip or eyelid margin) rather than in bone marrow, the tumor is classified as an extramedullary plasmacytoma.

Plasmacytomas make up approximately 1.5% of all canine cutaneous tumors and roughly 2.4% of biopsied skin masses in large pathology surveys. In the landmark case series of 75 mucocutaneous plasmacytomas, the mean age at diagnosis was 9.6 years, with a range of 2 to 17 years (Rakich et al., 1989). There is no consistent sex predisposition, but Cocker Spaniels, Airedale Terriers, Standard Poodles, Scottish Terriers, and West Highland White Terriers are reported more often than their population share would predict.

The clinically important point is that these are almost always solitary and biologically benign. Unlike multiple myeloma, which is a systemic malignancy of bone marrow plasma cells, cutaneous plasmacytoma stays put. It does not typically metastasize, it does not usually produce a monoclonal gammopathy (an excess of one antibody type in the blood), and complete surgical removal is curative in the large majority of dogs.

A minority of plasmacytomas deposit amyloid, a misfolded protein derived from immunoglobulin light chains, within the tumor. Amyloid-producing plasmacytomas look identical from the outside but are worth flagging on the biopsy report, because they may be slightly more likely to recur locally if incompletely excised.

What Causes Plasmacytoma in Dogs?

No single trigger has been identified for canine cutaneous plasmacytoma. The tumor arises when a single plasma cell acquires mutations that allow it to divide independently of the normal immune signals that switch antibody production on and off, producing a monoclonal (single-origin) mass of near-identical cells.

Several observations point toward chronic antigenic stimulation as a contributing factor. Plasmacytomas cluster at sites with heavy, continuous immune traffic: the lips, oral mucosa, ear canal and pinna, and the digits, all areas subject to repeated low-grade irritation, trauma, or microbial exposure. Long-standing inflammation drives sustained plasma cell proliferation in these tissues, which statistically increases the chance that one of those dividing cells picks up a transforming mutation.

Age is the strongest identified risk factor. More than 80% of affected dogs are 7 years or older, consistent with the accumulation of somatic mutations over a lifetime and with age-related decline in immune surveillance. There is no evidence linking canine cutaneous plasmacytoma to any virus, to vaccination, or to any specific dietary or environmental exposure.

Importantly, having a cutaneous plasmacytoma does not mean a dog has or will develop multiple myeloma. The two conditions share a cell of origin but not a clinical course. Progression from solitary cutaneous plasmacytoma to systemic myeloma is documented but uncommon, and is most often reported in dogs with multiple simultaneous lesions or with bone involvement.

How Do Veterinarians Diagnose Cutaneous Plasmacytoma?

Diagnosis follows a two-step sequence: fine needle aspirate cytology first, then histopathology with immunohistochemistry for confirmation. Cytology is fast, inexpensive, and usually performed without sedation, but it cannot reliably distinguish plasmacytoma from several look-alike round cell tumors.

On a stained aspirate, plasmacytoma yields a dense population of discrete round cells with eccentric nuclei (pushed to one side), deeply basophilic cytoplasm, and a pale perinuclear clear zone corresponding to the Golgi apparatus. Binucleate and multinucleate cells are common, and marked variation in nuclear size (anisokaryosis) is typical even in benign lesions. That cellular pleomorphism is why cytology reports frequently read as suspicious rather than definitive, and it is also why a plasmacytoma is sometimes over-called as a malignancy on cytology alone.

Histopathology on an excisional or incisional biopsy is the diagnostic standard. When the pathologist needs confirmation, immunohistochemistry for MUM1/IRF4 is the most useful single marker, staining positive in the overwhelming majority of canine plasmacytomas, supported by CD79a positivity and negative staining for CD3 and CD18 (Ramos-Vara et al., 2007). Congo red staining is added when amyloid is suspected. Notably, histopathological grade has not been shown to predict behavior in canine cutaneous plasmacytoma, so a report describing atypical or pleomorphic cells is not by itself a reason for alarm (Platz et al., 1999).

If a dog presents with multiple plasmacytomas, or with any lameness, bone pain, lethargy, increased drinking, or bleeding tendency, staging for multiple myeloma is warranted: complete blood count, serum biochemistry with calcium, serum protein electrophoresis to look for a monoclonal spike, urine testing for Bence Jones proteins, and skeletal radiographs.

Because these lesions are visually indistinct, owners who notice a new mass should have it evaluated rather than monitored. Reviewing our guides to fine needle aspirate for dog skin lumps and dog skin biopsy results can help you interpret what your veterinarian finds, and the Dog Skin Condition Checker is a useful starting point for describing what you are seeing.

Signs and Symptoms to Watch For

The classic presentation is a solitary, well-circumscribed, raised pink to red nodule measuring 0.5 to 2 cm, often smooth and hairless on the surface, sometimes ulcerated from self-trauma or friction. Growth is usually slow over weeks to months, and the mass is not typically painful unless it sits on a digit or is repeatedly licked.

Distribution matters. In published series, roughly one third occur on the digits and limbs, one quarter on the head including the ear pinna and canal, and a substantial share at the lips and within the oral cavity. Digital lesions can splay or deform the nail bed and are frequently mistaken for an infected nail or a squamous cell carcinoma.

Because plasmacytoma is a round cell tumor, its clinical appearance overlaps heavily with several far more concerning diagnoses. The table below summarizes the practical distinctions.

Treatment Options for Cutaneous Plasmacytoma

Complete surgical excision with narrow margins is the treatment of choice and is curative in the large majority of dogs. Because the tumor is benign and does not infiltrate widely, aggressive wide margins are rarely necessary. Reported local recurrence after complete excision is under 5%, and most recurrences trace back to incomplete removal rather than to aggressive tumor biology.

Anatomy sometimes dictates a modified approach. Digital plasmacytomas often require digit amputation because there is insufficient tissue to close a defect around the nail bed, and most dogs return to full function within two to three weeks. Oral and pharyngeal lesions may need marginal excision combined with radiation therapy when a complete resection would compromise function. Small superficial lesions in older dogs with anesthetic risk are sometimes managed with cryosurgery or CO2 laser ablation, though these techniques do not yield the clean margin assessment that scalpel excision provides. Radiation therapy is well documented as an effective adjunct for incompletely excised or non-resectable plasmacytomas, and systemic chemotherapy has essentially no role in solitary cutaneous disease.

Aftercare is where owners have the most influence on outcome. Surgical sites on the paw, muzzle, and ventral abdomen are prone to self-trauma and secondary bacterial contamination, and licking is the single most common cause of dehiscence (wound breakdown). Once your veterinarian confirms the incision has fully closed, gentle bathing helps clear crusted exudate, surface debris, and the residual irritation that keeps a dog licking. Itchy Skin Relief Shampoo combines colloidal oatmeal, which forms a hydrated barrier film over the stratum corneum and reduces the pruritic signaling that drives the itch and lick cycle, with aloe to support the surrounding skin during healing. It is formulated for irritated and reactive skin rather than for the tumor itself, and it should never be applied to an open or unhealed incision without veterinary direction.

Dogs with plasmacytomas on the ear, lip fold, or interdigital web frequently have concurrent low-grade inflammation in those same sites. Our guides to managing chronic itching in dogs and monthly at-home skin checks cover the routine that catches recurrences early, and the dry and flaky skin resource is useful if the surrounding coat becomes dull during recovery.

Prognosis and Long-Term Monitoring

The prognosis for solitary canine cutaneous plasmacytoma is excellent. Following complete excision, most dogs are considered cured, with survival determined by unrelated age-related disease rather than by the tumor. Across published series, the great majority of dogs remain free of local recurrence at long-term follow-up, and tumor-related death is rare.

Three findings warrant closer follow-up. First, incomplete margins on the histopathology report, which justify either a second surgery or a course of radiation. Second, multiple simultaneous plasmacytomas, which raise the index of suspicion for underlying systemic plasma cell disease and merit protein electrophoresis and skeletal imaging. Third, amyloid deposition within the tumor, which some pathologists associate with a higher rate of local regrowth.

Practical monitoring is straightforward. Recheck the surgical site at two weeks for suture removal and wound assessment, then examine the site and the rest of the body monthly at home. Run a hands-on check across the whole dog, including between the toes, along the lip margins, inside the ear pinnae, and around the anus, and record any new mass with a photograph and a measurement against a coin or ruler so change over time is objective rather than remembered.

Report any new nodule that persists beyond three weeks, any lesion that ulcerates or bleeds, and any systemic sign such as lethargy, increased thirst, lameness, or unexplained bruising. In an older dog, an annual blood panel is reasonable regardless, and it doubles as a screen for the systemic plasma cell disorders that sit on the differential list.

Frequently Asked Questions

Is a plasmacytoma in dogs cancerous?

Cutaneous plasmacytoma is a neoplasm, meaning an abnormal growth of cells, but it behaves benignly. It accounts for about 1.5% of canine skin tumors, rarely metastasizes, and complete surgical excision is curative in the large majority of dogs, with local recurrence reported in under 5% of cases.

How much does it cost to remove a plasmacytoma from a dog?

Costs vary by geography and by tumor location. A straightforward excision of a small trunk or limb mass under general anesthesia, including histopathology, typically falls in the range of several hundred to roughly 1,500 US dollars. Digital amputation or an oral resection sits at the higher end. Ask your veterinarian for a written estimate that specifies whether biopsy submission is included.

Can a plasmacytoma turn into multiple myeloma in dogs?

It is possible but uncommon. Solitary cutaneous plasmacytoma and multiple myeloma share a cell of origin, yet the vast majority of dogs with a single skin lesion never develop systemic disease. Progression is reported mainly in dogs with multiple simultaneous plasmacytomas or bone involvement, which is why those dogs receive serum protein electrophoresis, calcium measurement, urine testing for Bence Jones proteins, and skeletal radiographs.

What does a plasmacytoma look like on a dog?

Most appear as a solitary, raised, well-defined pink to red nodule measuring 0.5 to 2 cm, often smooth and hairless on the surface and sometimes ulcerated. The digits, ear pinnae, lips, muzzle, and oral cavity are the most common sites. Appearance alone cannot separate it from mast cell tumor, histiocytoma, or melanoma, so sampling is required.

Do plasmacytomas grow back after surgery in dogs?

Rarely. Local recurrence after complete excision is reported in fewer than 5% of dogs, and most recurrences follow incomplete margins on the biopsy report rather than aggressive tumor behavior. If your pathology report notes dirty or incomplete margins, or notes amyloid deposition within the tumor, discuss a second surgery or radiation therapy with your veterinarian.

Sources

1. Rakich PM, Latimer KS, Weiss R, Steffens WL. Mucocutaneous plasmacytomas in dogs: 75 cases (1980-1987). Journal of the American Veterinary Medical Association. 1989;194(6):803-810.
2. Cangul IT, Wijnen M, Van Garderen E, van den Ingh TSGAM. Clinico-pathological aspects of canine cutaneous and mucocutaneous plasmacytomas. Journal of Veterinary Medicine Series A. 2002;49(6):307-312.
3. Ramos-Vara JA, Miller MA, Valli VEO. Immunohistochemical detection of multiple myeloma 1/interferon regulatory factor 4 (MUM1/IRF-4) in canine plasmacytoma. Veterinary Pathology. 2007;44(6):875-884.
4. Platz SJ, Breuer W, Pfleghaar S, Minkus G, Hermanns W. Prognostic value of histopathological grading in canine extramedullary plasmacytomas. Veterinary Pathology. 1999;36(1):23-27.
5. Clark GN, Berg J, Engler SJ, Bergman PJ. Extramedullary plasmacytomas in dogs: results of surgical excision in 131 cases. Journal of the American Animal Hospital Association. 1992;28(2):105-111.

Related Reading

• Fine Needle Aspirate for Dog Skin Lumps: What to Expect and What Results Mean
• Dog Skin Lumps: Identify Bumps, Cysts & Masses
• Histiocytoma in Dogs: Benign Bump That Regresses

Emiel Maddens

Founder of Vetified. Develops topical antifungal and antimicrobial formulations for companion animals. Vetified products are listed on DailyMed and manufactured through FDA-registered facilities in the United States.

Veterinary review: All Vetified content is developed in consultation with licensed veterinary professionals and references peer-reviewed research published in journals including Veterinary Dermatology, JAVMA, and Journal of Small Animal Practice.